OSE IMMUNOTHERAPEUTICS Trademark
Trademark Overview
On Tuesday, June 25, 2024, a trademark application was filed for OSE IMMUNOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OSE IMMUNOTHERAPEUTICS trademark a serial number of 98617134. The federal status of this trademark filing is REGISTERED as of Tuesday, May 6, 2025. This trademark is owned by OSE Immunotherapeutics. The OSE IMMUNOTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services
Biological research; Biotechnology research; Database design and development; Design and development of computer software; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Pharmaceutical research services; Scientific and technological services, namely, research and design in the field of cancer treatment, oncology, and immunotherapy
General Information
| Serial Number | 98617134 |
| Word Mark | OSE IMMUNOTHERAPEUTICS |
| Filing Date | Tuesday, June 25, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 6, 2025 |
| Registration Number | 7783837 |
| Registration Date | Tuesday, May 6, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 18, 2025 |
Trademark Statements
| Goods and Services | Medical services |
| NOT AVAILABLE | "IMMUNOTHERAPEUTICS" |
| Goods and Services | Biological research; Biotechnology research; Database design and development; Design and development of computer software; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Pharmaceutical research services; Scientific and technological services, namely, research and design in the field of cancer treatment, oncology, and immunotherapy |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 25, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 25, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | OSE Immunotherapeutics |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Nantes 44200
FR |
| Party Name | OSE Immunotherapeutics |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Nantes 44200
FR |
| Party Name | OSE Immunotherapeutics |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Nantes 44200
FR |
Trademark Events
| Event Date | Event Description |
| Tuesday, June 25, 2024 | NEW APPLICATION ENTERED |
| Monday, January 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 15, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, January 22, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, March 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 18, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 6, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 6, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, February 11, 2025 | PUBLISHED FOR OPPOSITION |
